Clinical Pharmacokinetics of Oxazepam and Lorazepam

Clinical Pharmacokinetics

Volumn 6, Issue 2, 1981, Pages 89-105

  Greenblatt, David J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CIMETIDINE; DISULFIRAM; LORAZEPAM; OXAZEPAM; PLASMA PROTEIN;

DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; MAJOR CLINICAL STUDY; PHARMACOKINETICS; SEDATION;

AGING; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; DRUG INTERACTIONS; FEMALE; HUMAN; KIDNEY DISEASES; KINETICS; LIVER DISEASES; LORAZEPAM; OXAZEPAM; PREGNANCY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0019819202     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198106020-00001     Document Type: Article

References (58)

1. Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate
2. Pharmacokinetic study of lorazepam overdosage
3. Pharmacokinetics of oxazepam in healthy volunteers
4. Effects of different rates of absorption of two benzodiazepines on subjective and objective parameters
5. Placental transfer of lorazepam
6. Determination of lorazepam in plasma by electron capture GLC
7. Determination of 1,4-benzodiazepines and diazepin-2-ones in blood by electron-capture gas-liquid chromatography
8. Cimetidine impairs the elimination of chlordiazepoxide (Librium) in humans
9. Effect of heparin administration on plasma binding of benzodiazepines
10. Plasma lorazepam levels. A study following single dose administration of 2 and 4mg by different routes
11. Metabolism of lorazepam
12. Gas-liquid chromatography and mass spectrometry of various benzodiazepines
13. Gas Chromatographic degradation of several drugs and their metabolites
14. A simple electron-capture gas Chromatographie analysis of oxazepam in plasma by determination of its thermal degradation production
15. Intramuscular injection of drugs
16. Pharmacokinetics in clinical medicine: Oxazepam versus other benzodiazepines
17. 14C-lorazepam
18. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results
19. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection
20. Clinical pharmacokinetics of lorazepam. IV. Long-term oral administration
21. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography
22. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
23. Lorazepam kinetics in the elderly
24. Single- and multipledose kinetics of oral lorazepam in humans: The predictability of accumulation
25. Oxazepam kinetics: Effects of age and sex
26. Diazepam disposition determinants
27. Simplified determination of lorazepam and oxazepam in biological fluids by gas chromatography-mass spectrometry
28. Estimation of plasma lorazepam by gas-liquid chromatography and a benzene extraction
29. Plasma binding of benzodiazepines in humans
30. High-pressure liquid Chromatographic analysis of diazepam, oxazepam and N-desmethyldiazepam in human blood
31. Transfer of free and conjugated oxazepam across the human placenta
32. On the regulation of antipyrinc and oxazepam metabolism in man
33. Delayed clearance of diazepam due to Cimetidine
34. Absorption and excretion of 7-chloro-1, 3-dihydro-3-hydroxy-5-phenyl-2H-1, 4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection
35. Disposition of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in humans. Determination of the drug by electron capture gas chromatography
36. Effects of aging and liver disease on disposition of lorazepam
37. Bioavailability of lorazepam in humans
38. Clinical pharmacokinetics of lorazepam: A review
39. Interaction of disulfiram with benzodiazepines
40. A study of the plasma concentrations of lorazepam in mother and neonate
41. Bioavailability of oxazepam: Absence of influence of food intake
42. Entry of lorazepam into cerebrospinal fluid
43. Oxazepam disposition in uremic patients
44. Cimetidine spares the glucuronidation of lorazepam and oxazepam
45. Comparative bioavailability of oral dosage forms of oxazepam — correlation with in vitro dissolution rate
46. Comparative metabolism of lorazepam in man and four animal species
47. Thermolysis of 1,4-benzodiazepines during gas chromatography and mass spectroscopy
48. Differential effects on benzodiazepine disposition by disulfiram and ethanol
49. Chlordiazepoxide and oxazepam disposition in cirrhosis
50. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis
51. Placental passage of oxazepam and its metabolism in mother and newborn
52. Biotransformation and excretion of lorazepam in patients with chronic renal failure
53. Comparative pharmacokinetics of oxazepam and nortriptyline after single oral doses in man
54. Determination of oxazepam in serum and urine by electron capture gas chromatography
55. Determination of intact oxazepam by electron capture gas chromatography after an extractive alkylation reaction
56. Simultaneous determination of diazepam and its metabolites N-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography
57. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam, and lorazepam in man
58. Disposition of three benzodiazepines after single oral administration in man